nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—CYP1A1—head and neck cancer	0.546	1	CbGaD
Fluvoxamine—CYP2D6—Hydroxyurea—head and neck cancer	0.0604	0.197	CbGbCtD
Fluvoxamine—CYP3A7—Docetaxel—head and neck cancer	0.0383	0.125	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.0383	0.125	CbGbCtD
Fluvoxamine—CYP3A5—Docetaxel—head and neck cancer	0.0287	0.0937	CbGbCtD
Fluvoxamine—CYP1A2—Fluorouracil—head and neck cancer	0.028	0.0914	CbGbCtD
Fluvoxamine—CYP2C9—Fluorouracil—head and neck cancer	0.0252	0.0823	CbGbCtD
Fluvoxamine—ABCB1—Vinblastine—head and neck cancer	0.0227	0.074	CbGbCtD
Fluvoxamine—CYP2D6—Vinblastine—head and neck cancer	0.0214	0.0697	CbGbCtD
Fluvoxamine—ABCB1—Docetaxel—head and neck cancer	0.0187	0.061	CbGbCtD
Fluvoxamine—CYP3A4—Vinblastine—head and neck cancer	0.0136	0.0443	CbGbCtD
Fluvoxamine—CYP3A4—Docetaxel—head and neck cancer	0.0112	0.0366	CbGbCtD
Fluvoxamine—Bone disorder—Docetaxel—head and neck cancer	0.000499	0.00395	CcSEcCtD
Fluvoxamine—Agranulocytosis—Vinblastine—head and neck cancer	0.000497	0.00393	CcSEcCtD
Fluvoxamine—Weight increased—Hydroxyurea—head and neck cancer	0.000496	0.00392	CcSEcCtD
Fluvoxamine—Oliguria—Docetaxel—head and neck cancer	0.000489	0.00387	CcSEcCtD
Fluvoxamine—Drug interaction—Docetaxel—head and neck cancer	0.000486	0.00384	CcSEcCtD
Fluvoxamine—Drowsiness—Hydroxyurea—head and neck cancer	0.000485	0.00384	CcSEcCtD
Fluvoxamine—Amnesia—Fluorouracil—head and neck cancer	0.000483	0.00381	CcSEcCtD
Fluvoxamine—Haemoglobin—Vinblastine—head and neck cancer	0.00048	0.0038	CcSEcCtD
Fluvoxamine—Haemorrhage—Vinblastine—head and neck cancer	0.000478	0.00378	CcSEcCtD
Fluvoxamine—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000476	0.00376	CcSEcCtD
Fluvoxamine—Hypoaesthesia—Vinblastine—head and neck cancer	0.000475	0.00376	CcSEcCtD
Fluvoxamine—Dermatitis bullous—Fluorouracil—head and neck cancer	0.000474	0.00375	CcSEcCtD
Fluvoxamine—Pharyngitis—Vinblastine—head and neck cancer	0.000474	0.00375	CcSEcCtD
Fluvoxamine—Stomatitis—Hydroxyurea—head and neck cancer	0.000473	0.00374	CcSEcCtD
Fluvoxamine—Bone pain—Docetaxel—head and neck cancer	0.000471	0.00372	CcSEcCtD
Fluvoxamine—Cardiac failure—Fluorouracil—head and neck cancer	0.000465	0.00367	CcSEcCtD
Fluvoxamine—Lethargy—Fluorouracil—head and neck cancer	0.000463	0.00366	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000459	0.00363	CcSEcCtD
Fluvoxamine—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.000453	0.00358	CcSEcCtD
Fluvoxamine—Osteoarthritis—Fluorouracil—head and neck cancer	0.000453	0.00358	CcSEcCtD
Fluvoxamine—Haemoglobin—Hydroxyurea—head and neck cancer	0.000438	0.00346	CcSEcCtD
Fluvoxamine—Haemorrhage—Hydroxyurea—head and neck cancer	0.000436	0.00344	CcSEcCtD
Fluvoxamine—Hallucination—Hydroxyurea—head and neck cancer	0.000434	0.00343	CcSEcCtD
Fluvoxamine—Colitis—Docetaxel—head and neck cancer	0.000433	0.00342	CcSEcCtD
Fluvoxamine—Irritability—Fluorouracil—head and neck cancer	0.000433	0.00342	CcSEcCtD
Fluvoxamine—Cardiac arrest—Fluorouracil—head and neck cancer	0.000431	0.00341	CcSEcCtD
Fluvoxamine—Ataxia—Fluorouracil—head and neck cancer	0.000426	0.00337	CcSEcCtD
Fluvoxamine—Neuropathy—Docetaxel—head and neck cancer	0.000423	0.00335	CcSEcCtD
Fluvoxamine—Alopecia—Vinblastine—head and neck cancer	0.000422	0.00334	CcSEcCtD
Fluvoxamine—Dry skin—Fluorouracil—head and neck cancer	0.000416	0.00329	CcSEcCtD
Fluvoxamine—Oesophagitis—Docetaxel—head and neck cancer	0.000412	0.00326	CcSEcCtD
Fluvoxamine—Neoplasm—Docetaxel—head and neck cancer	0.000408	0.00322	CcSEcCtD
Fluvoxamine—Muscular weakness—Fluorouracil—head and neck cancer	0.0004	0.00316	CcSEcCtD
Fluvoxamine—Angiopathy—Hydroxyurea—head and neck cancer	0.000395	0.00313	CcSEcCtD
Fluvoxamine—Dysphagia—Fluorouracil—head and neck cancer	0.000392	0.0031	CcSEcCtD
Fluvoxamine—Chills—Hydroxyurea—head and neck cancer	0.000391	0.00309	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Vinblastine—head and neck cancer	0.000386	0.00305	CcSEcCtD
Fluvoxamine—Alopecia—Hydroxyurea—head and neck cancer	0.000385	0.00304	CcSEcCtD
Fluvoxamine—Anaemia—Vinblastine—head and neck cancer	0.000384	0.00304	CcSEcCtD
Fluvoxamine—Angina pectoris—Fluorouracil—head and neck cancer	0.000382	0.00302	CcSEcCtD
Fluvoxamine—Phlebitis—Docetaxel—head and neck cancer	0.00038	0.003	CcSEcCtD
Fluvoxamine—Malaise—Vinblastine—head and neck cancer	0.000375	0.00297	CcSEcCtD
Fluvoxamine—Vertigo—Vinblastine—head and neck cancer	0.000374	0.00295	CcSEcCtD
Fluvoxamine—Leukopenia—Vinblastine—head and neck cancer	0.000372	0.00294	CcSEcCtD
Fluvoxamine—Deafness—Docetaxel—head and neck cancer	0.000366	0.00289	CcSEcCtD
Fluvoxamine—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000364	0.00288	CcSEcCtD
Fluvoxamine—Convulsion—Vinblastine—head and neck cancer	0.00036	0.00285	CcSEcCtD
Fluvoxamine—Hypertension—Vinblastine—head and neck cancer	0.000359	0.00284	CcSEcCtD
Fluvoxamine—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000358	0.00283	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000352	0.00278	CcSEcCtD
Fluvoxamine—Pneumonia—Fluorouracil—head and neck cancer	0.000351	0.00278	CcSEcCtD
Fluvoxamine—Anaemia—Hydroxyurea—head and neck cancer	0.000351	0.00277	CcSEcCtD
Fluvoxamine—Discomfort—Vinblastine—head and neck cancer	0.00035	0.00277	CcSEcCtD
Fluvoxamine—Visual disturbance—Docetaxel—head and neck cancer	0.000345	0.00273	CcSEcCtD
Fluvoxamine—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000344	0.00272	CcSEcCtD
Fluvoxamine—Renal impairment—Docetaxel—head and neck cancer	0.000344	0.00272	CcSEcCtD
Fluvoxamine—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000343	0.00271	CcSEcCtD
Fluvoxamine—Myocardial infarction—Fluorouracil—head and neck cancer	0.000343	0.00271	CcSEcCtD
Fluvoxamine—Dermatitis bullous—Docetaxel—head and neck cancer	0.000342	0.00271	CcSEcCtD
Fluvoxamine—Malaise—Hydroxyurea—head and neck cancer	0.000342	0.0027	CcSEcCtD
Fluvoxamine—Stomatitis—Fluorouracil—head and neck cancer	0.000341	0.00269	CcSEcCtD
Fluvoxamine—Conjunctivitis—Fluorouracil—head and neck cancer	0.00034	0.00268	CcSEcCtD
Fluvoxamine—Urinary tract infection—Fluorouracil—head and neck cancer	0.00034	0.00268	CcSEcCtD
Fluvoxamine—Leukopenia—Hydroxyurea—head and neck cancer	0.00034	0.00268	CcSEcCtD
Fluvoxamine—Cardiac failure—Docetaxel—head and neck cancer	0.000335	0.00265	CcSEcCtD
Fluvoxamine—Lethargy—Docetaxel—head and neck cancer	0.000334	0.00264	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Vinblastine—head and neck cancer	0.000332	0.00263	CcSEcCtD
Fluvoxamine—Epistaxis—Fluorouracil—head and neck cancer	0.00033	0.00261	CcSEcCtD
Fluvoxamine—Convulsion—Hydroxyurea—head and neck cancer	0.000329	0.0026	CcSEcCtD
Fluvoxamine—Hyponatraemia—Docetaxel—head and neck cancer	0.000329	0.0026	CcSEcCtD
Fluvoxamine—Sinusitis—Fluorouracil—head and neck cancer	0.000328	0.00259	CcSEcCtD
Fluvoxamine—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000327	0.00259	CcSEcCtD
Fluvoxamine—Agranulocytosis—Fluorouracil—head and neck cancer	0.000326	0.00258	CcSEcCtD
Fluvoxamine—Anorexia—Vinblastine—head and neck cancer	0.000324	0.00256	CcSEcCtD
Fluvoxamine—Migraine—Docetaxel—head and neck cancer	0.000322	0.00255	CcSEcCtD
Fluvoxamine—Discomfort—Hydroxyurea—head and neck cancer	0.000319	0.00252	CcSEcCtD
Fluvoxamine—Haemoglobin—Fluorouracil—head and neck cancer	0.000315	0.00249	CcSEcCtD
Fluvoxamine—Rhinitis—Fluorouracil—head and neck cancer	0.000314	0.00249	CcSEcCtD
Fluvoxamine—Haemorrhage—Fluorouracil—head and neck cancer	0.000314	0.00248	CcSEcCtD
Fluvoxamine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000312	0.00247	CcSEcCtD
Fluvoxamine—Pharyngitis—Fluorouracil—head and neck cancer	0.000311	0.00246	CcSEcCtD
Fluvoxamine—Oedema—Hydroxyurea—head and neck cancer	0.00031	0.00245	CcSEcCtD
Fluvoxamine—Ataxia—Docetaxel—head and neck cancer	0.000308	0.00243	CcSEcCtD
Fluvoxamine—Infection—Hydroxyurea—head and neck cancer	0.000308	0.00243	CcSEcCtD
Fluvoxamine—Paraesthesia—Vinblastine—head and neck cancer	0.000305	0.00241	CcSEcCtD
Fluvoxamine—Dehydration—Docetaxel—head and neck cancer	0.000304	0.00241	CcSEcCtD
Fluvoxamine—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000304	0.0024	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000303	0.0024	CcSEcCtD
Fluvoxamine—Liver function test abnormal—Docetaxel—head and neck cancer	0.000302	0.00239	CcSEcCtD
Fluvoxamine—Dry skin—Docetaxel—head and neck cancer	0.0003	0.00237	CcSEcCtD
Fluvoxamine—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000299	0.00236	CcSEcCtD
Fluvoxamine—Breast disorder—Docetaxel—head and neck cancer	0.000296	0.00234	CcSEcCtD
Fluvoxamine—Anorexia—Hydroxyurea—head and neck cancer	0.000295	0.00233	CcSEcCtD
Fluvoxamine—Decreased appetite—Vinblastine—head and neck cancer	0.000295	0.00233	CcSEcCtD
Fluvoxamine—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000295	0.00233	CcSEcCtD
Fluvoxamine—Constipation—Vinblastine—head and neck cancer	0.00029	0.00229	CcSEcCtD
Fluvoxamine—Pain—Vinblastine—head and neck cancer	0.00029	0.00229	CcSEcCtD
Fluvoxamine—Dysphagia—Docetaxel—head and neck cancer	0.000283	0.00224	CcSEcCtD
Fluvoxamine—Arrhythmia—Fluorouracil—head and neck cancer	0.00028	0.00222	CcSEcCtD
Fluvoxamine—Feeling abnormal—Vinblastine—head and neck cancer	0.00028	0.00221	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000278	0.00219	CcSEcCtD
Fluvoxamine—Alopecia—Fluorouracil—head and neck cancer	0.000277	0.00219	CcSEcCtD
Fluvoxamine—Dyspnoea—Hydroxyurea—head and neck cancer	0.000276	0.00218	CcSEcCtD
Fluvoxamine—Angina pectoris—Docetaxel—head and neck cancer	0.000276	0.00218	CcSEcCtD
Fluvoxamine—Somnolence—Hydroxyurea—head and neck cancer	0.000275	0.00218	CcSEcCtD
Fluvoxamine—Dyspepsia—Hydroxyurea—head and neck cancer	0.000273	0.00215	CcSEcCtD
Fluvoxamine—Decreased appetite—Hydroxyurea—head and neck cancer	0.000269	0.00213	CcSEcCtD
Fluvoxamine—Abdominal pain—Vinblastine—head and neck cancer	0.000268	0.00212	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000267	0.00211	CcSEcCtD
Fluvoxamine—Fatigue—Hydroxyurea—head and neck cancer	0.000267	0.00211	CcSEcCtD
Fluvoxamine—Constipation—Hydroxyurea—head and neck cancer	0.000265	0.00209	CcSEcCtD
Fluvoxamine—Pain—Hydroxyurea—head and neck cancer	0.000265	0.00209	CcSEcCtD
Fluvoxamine—Weight increased—Docetaxel—head and neck cancer	0.000257	0.00203	CcSEcCtD
Fluvoxamine—Vision blurred—Fluorouracil—head and neck cancer	0.000257	0.00203	CcSEcCtD
Fluvoxamine—Weight decreased—Docetaxel—head and neck cancer	0.000256	0.00202	CcSEcCtD
Fluvoxamine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000255	0.00202	CcSEcCtD
Fluvoxamine—Pneumonia—Docetaxel—head and neck cancer	0.000254	0.00201	CcSEcCtD
Fluvoxamine—Anaemia—Fluorouracil—head and neck cancer	0.000252	0.002	CcSEcCtD
Fluvoxamine—Hypersensitivity—Vinblastine—head and neck cancer	0.00025	0.00198	CcSEcCtD
Fluvoxamine—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00025	0.00198	CcSEcCtD
Fluvoxamine—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000249	0.00197	CcSEcCtD
Fluvoxamine—Renal failure—Docetaxel—head and neck cancer	0.000248	0.00196	CcSEcCtD
Fluvoxamine—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000247	0.00195	CcSEcCtD
Fluvoxamine—Myocardial infarction—Docetaxel—head and neck cancer	0.000247	0.00195	CcSEcCtD
Fluvoxamine—Stomatitis—Docetaxel—head and neck cancer	0.000246	0.00194	CcSEcCtD
Fluvoxamine—Jaundice—Docetaxel—head and neck cancer	0.000246	0.00194	CcSEcCtD
Fluvoxamine—Conjunctivitis—Docetaxel—head and neck cancer	0.000245	0.00194	CcSEcCtD
Fluvoxamine—Body temperature increased—Hydroxyurea—head and neck cancer	0.000245	0.00193	CcSEcCtD
Fluvoxamine—Leukopenia—Fluorouracil—head and neck cancer	0.000244	0.00193	CcSEcCtD
Fluvoxamine—Asthenia—Vinblastine—head and neck cancer	0.000244	0.00193	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000239	0.00189	CcSEcCtD
Fluvoxamine—Epistaxis—Docetaxel—head and neck cancer	0.000238	0.00188	CcSEcCtD
Fluvoxamine—Convulsion—Fluorouracil—head and neck cancer	0.000237	0.00187	CcSEcCtD
Fluvoxamine—Agranulocytosis—Docetaxel—head and neck cancer	0.000235	0.00186	CcSEcCtD
Fluvoxamine—Chest pain—Fluorouracil—head and neck cancer	0.000232	0.00184	CcSEcCtD
Fluvoxamine—Myalgia—Fluorouracil—head and neck cancer	0.000232	0.00184	CcSEcCtD
Fluvoxamine—Diarrhoea—Vinblastine—head and neck cancer	0.000232	0.00184	CcSEcCtD
Fluvoxamine—Discomfort—Fluorouracil—head and neck cancer	0.00023	0.00182	CcSEcCtD
Fluvoxamine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000228	0.0018	CcSEcCtD
Fluvoxamine—Haemoglobin—Docetaxel—head and neck cancer	0.000228	0.0018	CcSEcCtD
Fluvoxamine—Rhinitis—Docetaxel—head and neck cancer	0.000227	0.00179	CcSEcCtD
Fluvoxamine—Hepatitis—Docetaxel—head and neck cancer	0.000226	0.00179	CcSEcCtD
Fluvoxamine—Haemorrhage—Docetaxel—head and neck cancer	0.000226	0.00179	CcSEcCtD
Fluvoxamine—Hypoaesthesia—Docetaxel—head and neck cancer	0.000225	0.00178	CcSEcCtD
Fluvoxamine—Confusional state—Fluorouracil—head and neck cancer	0.000225	0.00178	CcSEcCtD
Fluvoxamine—Pharyngitis—Docetaxel—head and neck cancer	0.000225	0.00178	CcSEcCtD
Fluvoxamine—Dizziness—Vinblastine—head and neck cancer	0.000225	0.00177	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Docetaxel—head and neck cancer	0.000224	0.00177	CcSEcCtD
Fluvoxamine—Oedema peripheral—Docetaxel—head and neck cancer	0.000223	0.00176	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000223	0.00176	CcSEcCtD
Fluvoxamine—Oedema—Fluorouracil—head and neck cancer	0.000223	0.00176	CcSEcCtD
Fluvoxamine—Asthenia—Hydroxyurea—head and neck cancer	0.000222	0.00176	CcSEcCtD
Fluvoxamine—Urethral disorder—Docetaxel—head and neck cancer	0.000222	0.00175	CcSEcCtD
Fluvoxamine—Infection—Fluorouracil—head and neck cancer	0.000221	0.00175	CcSEcCtD
Fluvoxamine—Nervous system disorder—Fluorouracil—head and neck cancer	0.000219	0.00173	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000218	0.00172	CcSEcCtD
Fluvoxamine—Visual impairment—Docetaxel—head and neck cancer	0.000218	0.00172	CcSEcCtD
Fluvoxamine—Tachycardia—Fluorouracil—head and neck cancer	0.000218	0.00172	CcSEcCtD
Fluvoxamine—Vomiting—Vinblastine—head and neck cancer	0.000216	0.00171	CcSEcCtD
Fluvoxamine—Erythema multiforme—Docetaxel—head and neck cancer	0.000214	0.00169	CcSEcCtD
Fluvoxamine—Headache—Vinblastine—head and neck cancer	0.000213	0.00168	CcSEcCtD
Fluvoxamine—Anorexia—Fluorouracil—head and neck cancer	0.000212	0.00168	CcSEcCtD
Fluvoxamine—Diarrhoea—Hydroxyurea—head and neck cancer	0.000212	0.00167	CcSEcCtD
Fluvoxamine—Eye disorder—Docetaxel—head and neck cancer	0.000212	0.00167	CcSEcCtD
Fluvoxamine—Cardiac disorder—Docetaxel—head and neck cancer	0.00021	0.00166	CcSEcCtD
Fluvoxamine—Hypotension—Fluorouracil—head and neck cancer	0.000208	0.00165	CcSEcCtD
Fluvoxamine—Angiopathy—Docetaxel—head and neck cancer	0.000205	0.00162	CcSEcCtD
Fluvoxamine—Dizziness—Hydroxyurea—head and neck cancer	0.000205	0.00162	CcSEcCtD
Fluvoxamine—Chills—Docetaxel—head and neck cancer	0.000203	0.00161	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000203	0.0016	CcSEcCtD
Fluvoxamine—Arrhythmia—Docetaxel—head and neck cancer	0.000202	0.0016	CcSEcCtD
Fluvoxamine—Nausea—Vinblastine—head and neck cancer	0.000202	0.00159	CcSEcCtD
Fluvoxamine—Insomnia—Fluorouracil—head and neck cancer	0.000202	0.00159	CcSEcCtD
Fluvoxamine—Paraesthesia—Fluorouracil—head and neck cancer	0.0002	0.00158	CcSEcCtD
Fluvoxamine—Alopecia—Docetaxel—head and neck cancer	0.0002	0.00158	CcSEcCtD
Fluvoxamine—Dyspnoea—Fluorouracil—head and neck cancer	0.000199	0.00157	CcSEcCtD
Fluvoxamine—Mental disorder—Docetaxel—head and neck cancer	0.000198	0.00157	CcSEcCtD
Fluvoxamine—Somnolence—Fluorouracil—head and neck cancer	0.000198	0.00157	CcSEcCtD
Fluvoxamine—Malnutrition—Docetaxel—head and neck cancer	0.000197	0.00156	CcSEcCtD
Fluvoxamine—Vomiting—Hydroxyurea—head and neck cancer	0.000197	0.00156	CcSEcCtD
Fluvoxamine—Dyspepsia—Fluorouracil—head and neck cancer	0.000196	0.00155	CcSEcCtD
Fluvoxamine—Rash—Hydroxyurea—head and neck cancer	0.000195	0.00154	CcSEcCtD
Fluvoxamine—Dermatitis—Hydroxyurea—head and neck cancer	0.000195	0.00154	CcSEcCtD
Fluvoxamine—Headache—Hydroxyurea—head and neck cancer	0.000194	0.00153	CcSEcCtD
Fluvoxamine—Decreased appetite—Fluorouracil—head and neck cancer	0.000194	0.00153	CcSEcCtD
Fluvoxamine—Dysgeusia—Docetaxel—head and neck cancer	0.000193	0.00153	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000192	0.00152	CcSEcCtD
Fluvoxamine—Back pain—Docetaxel—head and neck cancer	0.000191	0.00151	CcSEcCtD
Fluvoxamine—Pain—Fluorouracil—head and neck cancer	0.000191	0.00151	CcSEcCtD
Fluvoxamine—Muscle spasms—Docetaxel—head and neck cancer	0.000189	0.0015	CcSEcCtD
Fluvoxamine—Nausea—Hydroxyurea—head and neck cancer	0.000184	0.00145	CcSEcCtD
Fluvoxamine—Feeling abnormal—Fluorouracil—head and neck cancer	0.000184	0.00145	CcSEcCtD
Fluvoxamine—Anaemia—Docetaxel—head and neck cancer	0.000182	0.00144	CcSEcCtD
Fluvoxamine—Urticaria—Fluorouracil—head and neck cancer	0.000177	0.0014	CcSEcCtD
Fluvoxamine—Syncope—Docetaxel—head and neck cancer	0.000177	0.0014	CcSEcCtD
Fluvoxamine—Leukopenia—Docetaxel—head and neck cancer	0.000176	0.00139	CcSEcCtD
Fluvoxamine—Body temperature increased—Fluorouracil—head and neck cancer	0.000176	0.00139	CcSEcCtD
Fluvoxamine—Palpitations—Docetaxel—head and neck cancer	0.000174	0.00138	CcSEcCtD
Fluvoxamine—Loss of consciousness—Docetaxel—head and neck cancer	0.000173	0.00137	CcSEcCtD
Fluvoxamine—Cough—Docetaxel—head and neck cancer	0.000172	0.00136	CcSEcCtD
Fluvoxamine—Convulsion—Docetaxel—head and neck cancer	0.000171	0.00135	CcSEcCtD
Fluvoxamine—Hypertension—Docetaxel—head and neck cancer	0.00017	0.00135	CcSEcCtD
Fluvoxamine—Chest pain—Docetaxel—head and neck cancer	0.000168	0.00133	CcSEcCtD
Fluvoxamine—Myalgia—Docetaxel—head and neck cancer	0.000168	0.00133	CcSEcCtD
Fluvoxamine—Arthralgia—Docetaxel—head and neck cancer	0.000168	0.00133	CcSEcCtD
Fluvoxamine—Hypersensitivity—Fluorouracil—head and neck cancer	0.000164	0.0013	CcSEcCtD
Fluvoxamine—Dry mouth—Docetaxel—head and neck cancer	0.000164	0.0013	CcSEcCtD
Fluvoxamine—Confusional state—Docetaxel—head and neck cancer	0.000162	0.00128	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Docetaxel—head and neck cancer	0.000161	0.00127	CcSEcCtD
Fluvoxamine—Oedema—Docetaxel—head and neck cancer	0.000161	0.00127	CcSEcCtD
Fluvoxamine—Infection—Docetaxel—head and neck cancer	0.00016	0.00126	CcSEcCtD
Fluvoxamine—Shock—Docetaxel—head and neck cancer	0.000158	0.00125	CcSEcCtD
Fluvoxamine—Nervous system disorder—Docetaxel—head and neck cancer	0.000158	0.00125	CcSEcCtD
Fluvoxamine—Pruritus—Fluorouracil—head and neck cancer	0.000158	0.00125	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Docetaxel—head and neck cancer	0.000157	0.00124	CcSEcCtD
Fluvoxamine—Tachycardia—Docetaxel—head and neck cancer	0.000157	0.00124	CcSEcCtD
Fluvoxamine—Anorexia—Docetaxel—head and neck cancer	0.000153	0.00121	CcSEcCtD
Fluvoxamine—Diarrhoea—Fluorouracil—head and neck cancer	0.000152	0.00121	CcSEcCtD
Fluvoxamine—Hypotension—Docetaxel—head and neck cancer	0.00015	0.00119	CcSEcCtD
Fluvoxamine—Dizziness—Fluorouracil—head and neck cancer	0.000147	0.00116	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000147	0.00116	CcSEcCtD
Fluvoxamine—Insomnia—Docetaxel—head and neck cancer	0.000145	0.00115	CcSEcCtD
Fluvoxamine—Paraesthesia—Docetaxel—head and neck cancer	0.000144	0.00114	CcSEcCtD
Fluvoxamine—Dyspnoea—Docetaxel—head and neck cancer	0.000143	0.00113	CcSEcCtD
Fluvoxamine—Somnolence—Docetaxel—head and neck cancer	0.000143	0.00113	CcSEcCtD
Fluvoxamine—Vomiting—Fluorouracil—head and neck cancer	0.000142	0.00112	CcSEcCtD
Fluvoxamine—Dyspepsia—Docetaxel—head and neck cancer	0.000142	0.00112	CcSEcCtD
Fluvoxamine—Rash—Fluorouracil—head and neck cancer	0.000141	0.00111	CcSEcCtD
Fluvoxamine—Dermatitis—Fluorouracil—head and neck cancer	0.00014	0.00111	CcSEcCtD
Fluvoxamine—Decreased appetite—Docetaxel—head and neck cancer	0.00014	0.00111	CcSEcCtD
Fluvoxamine—Headache—Fluorouracil—head and neck cancer	0.00014	0.0011	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000139	0.0011	CcSEcCtD
Fluvoxamine—Fatigue—Docetaxel—head and neck cancer	0.000139	0.0011	CcSEcCtD
Fluvoxamine—Constipation—Docetaxel—head and neck cancer	0.000138	0.00109	CcSEcCtD
Fluvoxamine—Pain—Docetaxel—head and neck cancer	0.000138	0.00109	CcSEcCtD
Fluvoxamine—Feeling abnormal—Docetaxel—head and neck cancer	0.000133	0.00105	CcSEcCtD
Fluvoxamine—Nausea—Fluorouracil—head and neck cancer	0.000132	0.00105	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000132	0.00104	CcSEcCtD
Fluvoxamine—Abdominal pain—Docetaxel—head and neck cancer	0.000127	0.00101	CcSEcCtD
Fluvoxamine—Body temperature increased—Docetaxel—head and neck cancer	0.000127	0.00101	CcSEcCtD
Fluvoxamine—Hypersensitivity—Docetaxel—head and neck cancer	0.000119	0.000937	CcSEcCtD
Fluvoxamine—Asthenia—Docetaxel—head and neck cancer	0.000115	0.000912	CcSEcCtD
Fluvoxamine—Pruritus—Docetaxel—head and neck cancer	0.000114	0.0009	CcSEcCtD
Fluvoxamine—Diarrhoea—Docetaxel—head and neck cancer	0.00011	0.00087	CcSEcCtD
Fluvoxamine—Dizziness—Docetaxel—head and neck cancer	0.000106	0.000841	CcSEcCtD
Fluvoxamine—Vomiting—Docetaxel—head and neck cancer	0.000102	0.000808	CcSEcCtD
Fluvoxamine—Rash—Docetaxel—head and neck cancer	0.000101	0.000802	CcSEcCtD
Fluvoxamine—Dermatitis—Docetaxel—head and neck cancer	0.000101	0.000801	CcSEcCtD
Fluvoxamine—Headache—Docetaxel—head and neck cancer	0.000101	0.000797	CcSEcCtD
Fluvoxamine—Nausea—Docetaxel—head and neck cancer	9.55e-05	0.000755	CcSEcCtD
Fluvoxamine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	6.13e-05	0.00292	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metapathway biotransformation—GSTM1—head and neck cancer	6.06e-05	0.00289	CbGpPWpGaD
Fluvoxamine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	5.89e-05	0.00281	CbGpPWpGaD
Fluvoxamine—CYP3A7—Biological oxidations—CYP1A1—head and neck cancer	5.82e-05	0.00278	CbGpPWpGaD
Fluvoxamine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	5.81e-05	0.00277	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metapathway biotransformation—CYP1A1—head and neck cancer	5.74e-05	0.00274	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	5.7e-05	0.00272	CbGpPWpGaD
Fluvoxamine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	5.63e-05	0.00269	CbGpPWpGaD
Fluvoxamine—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	5.62e-05	0.00268	CbGpPWpGaD
Fluvoxamine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	5.59e-05	0.00266	CbGpPWpGaD
Fluvoxamine—CYP1A2—Biological oxidations—NAT2—head and neck cancer	5.41e-05	0.00258	CbGpPWpGaD
Fluvoxamine—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—head and neck cancer	5.39e-05	0.00257	CbGpPWpGaD
Fluvoxamine—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	5.35e-05	0.00255	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	5.34e-05	0.00255	CbGpPWpGaD
Fluvoxamine—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	5.2e-05	0.00248	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	5.19e-05	0.00247	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—UROD—head and neck cancer	5.12e-05	0.00244	CbGpPWpGaD
Fluvoxamine—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	4.82e-05	0.0023	CbGpPWpGaD
Fluvoxamine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	4.81e-05	0.00229	CbGpPWpGaD
Fluvoxamine—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	4.81e-05	0.00229	CbGpPWpGaD
Fluvoxamine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	4.77e-05	0.00227	CbGpPWpGaD
Fluvoxamine—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	4.74e-05	0.00226	CbGpPWpGaD
Fluvoxamine—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	4.57e-05	0.00218	CbGpPWpGaD
Fluvoxamine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	4.54e-05	0.00217	CbGpPWpGaD
Fluvoxamine—CYP2B6—Biological oxidations—GSTM1—head and neck cancer	4.54e-05	0.00216	CbGpPWpGaD
Fluvoxamine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	4.48e-05	0.00214	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metapathway biotransformation—GSTM1—head and neck cancer	4.48e-05	0.00214	CbGpPWpGaD
Fluvoxamine—CYP2E1—Biological oxidations—GSTM1—head and neck cancer	4.45e-05	0.00212	CbGpPWpGaD
Fluvoxamine—CYP3A5—Biological oxidations—GSTM1—head and neck cancer	4.44e-05	0.00212	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metapathway biotransformation—GSTM1—head and neck cancer	4.39e-05	0.00209	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	4.38e-05	0.00209	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	4.33e-05	0.00206	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—CASP8—head and neck cancer	4.32e-05	0.00206	CbGpPWpGaD
Fluvoxamine—CYP2B6—Biological oxidations—CYP1A1—head and neck cancer	4.31e-05	0.00205	CbGpPWpGaD
Fluvoxamine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	4.25e-05	0.00202	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metapathway biotransformation—CYP1A1—head and neck cancer	4.25e-05	0.00202	CbGpPWpGaD
Fluvoxamine—CYP2E1—Biological oxidations—CYP1A1—head and neck cancer	4.22e-05	0.00201	CbGpPWpGaD
Fluvoxamine—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	4.21e-05	0.00201	CbGpPWpGaD
Fluvoxamine—CYP1A1—Biological oxidations—GSTM1—head and neck cancer	4.19e-05	0.002	CbGpPWpGaD
Fluvoxamine—CYP3A4—Biological oxidations—NAT2—head and neck cancer	4.18e-05	0.00199	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metapathway biotransformation—CYP1A1—head and neck cancer	4.16e-05	0.00198	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	4.15e-05	0.00198	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metapathway biotransformation—GSTM1—head and neck cancer	4.14e-05	0.00197	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	4.12e-05	0.00196	CbGpPWpGaD
Fluvoxamine—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	4.05e-05	0.00193	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	4.01e-05	0.00191	CbGpPWpGaD
Fluvoxamine—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	3.87e-05	0.00184	CbGpPWpGaD
Fluvoxamine—SLC6A4—Circadian rythm related genes—PTEN—head and neck cancer	3.84e-05	0.00183	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—UROD—head and neck cancer	3.79e-05	0.00181	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—UROD—head and neck cancer	3.71e-05	0.00177	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—UROD—head and neck cancer	3.7e-05	0.00176	CbGpPWpGaD
Fluvoxamine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	3.68e-05	0.00176	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—UROD—head and neck cancer	3.5e-05	0.00167	CbGpPWpGaD
Fluvoxamine—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	3.43e-05	0.00164	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	3.41e-05	0.00163	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	3.39e-05	0.00161	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—IL2—head and neck cancer	3.26e-05	0.00155	CbGpPWpGaD
Fluvoxamine—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	3.25e-05	0.00155	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	3.21e-05	0.00153	CbGpPWpGaD
Fluvoxamine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	3.2e-05	0.00153	CbGpPWpGaD
Fluvoxamine—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	3.16e-05	0.0015	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	3.13e-05	0.00149	CbGpPWpGaD
Fluvoxamine—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	3.13e-05	0.00149	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	3.12e-05	0.00149	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	3.11e-05	0.00148	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	3.09e-05	0.00147	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	3.07e-05	0.00146	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	3.07e-05	0.00146	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	3.07e-05	0.00146	CbGpPWpGaD
Fluvoxamine—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	2.99e-05	0.00143	CbGpPWpGaD
Fluvoxamine—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	2.97e-05	0.00141	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	2.95e-05	0.00141	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	2.93e-05	0.00139	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—UROD—head and neck cancer	2.86e-05	0.00136	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—UROD—head and neck cancer	2.79e-05	0.00133	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	2.77e-05	0.00132	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	2.71e-05	0.00129	CbGpPWpGaD
Fluvoxamine—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	2.67e-05	0.00127	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	2.64e-05	0.00126	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—UROD—head and neck cancer	2.63e-05	0.00125	CbGpPWpGaD
Fluvoxamine—SLC6A4—Circadian rythm related genes—TP53—head and neck cancer	2.62e-05	0.00125	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—UROD—head and neck cancer	2.61e-05	0.00124	CbGpPWpGaD
Fluvoxamine—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	2.54e-05	0.00121	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	2.5e-05	0.00119	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	2.46e-05	0.00117	CbGpPWpGaD
Fluvoxamine—SLC6A3—Transmission across Chemical Synapses—MAPK1—head and neck cancer	2.39e-05	0.00114	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—UROD—head and neck cancer	2.23e-05	0.00106	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	2.22e-05	0.00106	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	2.13e-05	0.00102	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—NAT2—head and neck cancer	2.13e-05	0.00101	CbGpPWpGaD
Fluvoxamine—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	2.06e-05	0.000984	CbGpPWpGaD
Fluvoxamine—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	2.04e-05	0.000974	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	2.04e-05	0.00097	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	2.02e-05	0.000965	CbGpPWpGaD
Fluvoxamine—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	1.96e-05	0.000933	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	1.93e-05	0.00092	CbGpPWpGaD
Fluvoxamine—SLC6A3—Transmission across Chemical Synapses—HRAS—head and neck cancer	1.92e-05	0.000914	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—DPYD—head and neck cancer	1.86e-05	0.000889	CbGpPWpGaD
Fluvoxamine—SLC6A3—Neuronal System—MAPK1—head and neck cancer	1.83e-05	0.000872	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	1.83e-05	0.000871	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—YAP1—head and neck cancer	1.77e-05	0.000843	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	1.74e-05	0.000828	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	1.73e-05	0.000825	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—UROD—head and neck cancer	1.72e-05	0.00082	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—NAT2—head and neck cancer	1.57e-05	0.00075	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	1.57e-05	0.000748	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.54e-05	0.000735	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—NAT2—head and neck cancer	1.54e-05	0.000734	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—NAT2—head and neck cancer	1.54e-05	0.000733	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	1.51e-05	0.000722	CbGpPWpGaD
Fluvoxamine—SLC6A3—Neuronal System—HRAS—head and neck cancer	1.47e-05	0.0007	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—NAT2—head and neck cancer	1.45e-05	0.000692	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—DPYD—head and neck cancer	1.38e-05	0.000657	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	1.37e-05	0.000652	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—DPYD—head and neck cancer	1.35e-05	0.000644	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—DPYD—head and neck cancer	1.35e-05	0.000642	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—YAP1—head and neck cancer	1.31e-05	0.000624	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	1.29e-05	0.000617	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—YAP1—head and neck cancer	1.28e-05	0.000611	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—YAP1—head and neck cancer	1.28e-05	0.00061	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—DPYD—head and neck cancer	1.27e-05	0.000607	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.26e-05	0.000602	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.25e-05	0.000596	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	1.23e-05	0.000587	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	1.23e-05	0.000587	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—YAP1—head and neck cancer	1.21e-05	0.000576	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—NAT2—head and neck cancer	1.19e-05	0.000566	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—NAT2—head and neck cancer	1.16e-05	0.000553	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.15e-05	0.000549	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.14e-05	0.000543	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—NAT2—head and neck cancer	1.09e-05	0.000521	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—NAT2—head and neck cancer	1.08e-05	0.000517	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	1.07e-05	0.000509	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—TYMS—head and neck cancer	1.06e-05	0.000506	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—GSTM1—head and neck cancer	1.05e-05	0.000501	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—DPYD—head and neck cancer	1.04e-05	0.000497	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	1.03e-05	0.000493	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—DPYD—head and neck cancer	1.02e-05	0.000485	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—GPX1—head and neck cancer	1.01e-05	0.000479	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—CYP1A1—head and neck cancer	9.96e-06	0.000475	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—YAP1—head and neck cancer	9.89e-06	0.000471	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	9.83e-06	0.000469	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	9.74e-06	0.000464	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—YAP1—head and neck cancer	9.65e-06	0.00046	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—DPYD—head and neck cancer	9.59e-06	0.000457	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—DPYD—head and neck cancer	9.5e-06	0.000453	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—NAT2—head and neck cancer	9.26e-06	0.000441	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—YAP1—head and neck cancer	9.1e-06	0.000434	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	9.08e-06	0.000433	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—YAP1—head and neck cancer	9.02e-06	0.00043	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	8.73e-06	0.000416	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—DPYD—head and neck cancer	8.12e-06	0.000387	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	7.92e-06	0.000377	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—TYMS—head and neck cancer	7.86e-06	0.000375	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GSTM1—head and neck cancer	7.77e-06	0.00037	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—YAP1—head and neck cancer	7.71e-06	0.000367	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—TYMS—head and neck cancer	7.7e-06	0.000367	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—TYMS—head and neck cancer	7.68e-06	0.000366	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GSTM1—head and neck cancer	7.61e-06	0.000363	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GSTM1—head and neck cancer	7.59e-06	0.000362	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GPX1—head and neck cancer	7.44e-06	0.000355	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	7.43e-06	0.000354	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CYP1A1—head and neck cancer	7.36e-06	0.000351	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GPX1—head and neck cancer	7.29e-06	0.000347	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GPX1—head and neck cancer	7.27e-06	0.000347	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—TYMS—head and neck cancer	7.26e-06	0.000346	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CYP1A1—head and neck cancer	7.21e-06	0.000344	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CYP1A1—head and neck cancer	7.2e-06	0.000343	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GSTM1—head and neck cancer	7.17e-06	0.000342	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NAT2—head and neck cancer	7.15e-06	0.000341	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GPX1—head and neck cancer	6.87e-06	0.000327	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	6.78e-06	0.000323	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.48e-06	0.000309	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—DPYD—head and neck cancer	6.27e-06	0.000299	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—YAP1—head and neck cancer	5.95e-06	0.000283	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—TYMS—head and neck cancer	5.94e-06	0.000283	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PTGS2—head and neck cancer	5.92e-06	0.000282	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	5.91e-06	0.000282	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GSTM1—head and neck cancer	5.87e-06	0.00028	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—TYMS—head and neck cancer	5.8e-06	0.000276	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.79e-06	0.000276	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GSTM1—head and neck cancer	5.73e-06	0.000273	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GPX1—head and neck cancer	5.62e-06	0.000268	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.59e-06	0.000266	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CYP1A1—head and neck cancer	5.56e-06	0.000265	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GPX1—head and neck cancer	5.49e-06	0.000262	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—TYMS—head and neck cancer	5.46e-06	0.00026	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CYP1A1—head and neck cancer	5.43e-06	0.000259	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—TYMS—head and neck cancer	5.41e-06	0.000258	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GSTM1—head and neck cancer	5.4e-06	0.000257	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GSTM1—head and neck cancer	5.35e-06	0.000255	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GPX1—head and neck cancer	5.17e-06	0.000246	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PTEN—head and neck cancer	5.16e-06	0.000246	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GPX1—head and neck cancer	5.13e-06	0.000244	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CYP1A1—head and neck cancer	5.12e-06	0.000244	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYP1A1—head and neck cancer	5.07e-06	0.000242	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	5.05e-06	0.000241	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—TYMS—head and neck cancer	4.63e-06	0.000221	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GSTM1—head and neck cancer	4.57e-06	0.000218	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.57e-06	0.000218	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GPX1—head and neck cancer	4.38e-06	0.000209	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PTGS2—head and neck cancer	4.38e-06	0.000209	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP1A1—head and neck cancer	4.34e-06	0.000207	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PTGS2—head and neck cancer	4.29e-06	0.000204	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PTGS2—head and neck cancer	4.28e-06	0.000204	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.17e-06	0.000199	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PTGS2—head and neck cancer	4.04e-06	0.000193	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PTEN—head and neck cancer	3.82e-06	0.000182	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PTEN—head and neck cancer	3.74e-06	0.000178	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PTEN—head and neck cancer	3.73e-06	0.000178	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PIK3CA—head and neck cancer	3.64e-06	0.000174	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—TYMS—head and neck cancer	3.57e-06	0.00017	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.56e-06	0.00017	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GSTM1—head and neck cancer	3.53e-06	0.000168	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PTEN—head and neck cancer	3.53e-06	0.000168	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GPX1—head and neck cancer	3.38e-06	0.000161	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	3.35e-06	0.000159	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PTGS2—head and neck cancer	3.31e-06	0.000158	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PTGS2—head and neck cancer	3.23e-06	0.000154	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PTGS2—head and neck cancer	3.04e-06	0.000145	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PTGS2—head and neck cancer	3.02e-06	0.000144	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—AKT1—head and neck cancer	2.98e-06	0.000142	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PTEN—head and neck cancer	2.89e-06	0.000138	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PTEN—head and neck cancer	2.82e-06	0.000134	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PIK3CA—head and neck cancer	2.69e-06	0.000128	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PTEN—head and neck cancer	2.65e-06	0.000127	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PIK3CA—head and neck cancer	2.64e-06	0.000126	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PIK3CA—head and neck cancer	2.63e-06	0.000126	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PTEN—head and neck cancer	2.63e-06	0.000125	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PTGS2—head and neck cancer	2.58e-06	0.000123	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PIK3CA—head and neck cancer	2.49e-06	0.000119	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PTEN—head and neck cancer	2.25e-06	0.000107	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—AKT1—head and neck cancer	2.2e-06	0.000105	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—AKT1—head and neck cancer	2.16e-06	0.000103	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—AKT1—head and neck cancer	2.15e-06	0.000103	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PIK3CA—head and neck cancer	2.04e-06	9.7e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—AKT1—head and neck cancer	2.03e-06	9.69e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.99e-06	9.48e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PIK3CA—head and neck cancer	1.99e-06	9.47e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PIK3CA—head and neck cancer	1.87e-06	8.93e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PIK3CA—head and neck cancer	1.86e-06	8.85e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PTEN—head and neck cancer	1.74e-06	8.27e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—AKT1—head and neck cancer	1.66e-06	7.93e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—AKT1—head and neck cancer	1.62e-06	7.74e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PIK3CA—head and neck cancer	1.59e-06	7.56e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—AKT1—head and neck cancer	1.53e-06	7.29e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—AKT1—head and neck cancer	1.52e-06	7.23e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—AKT1—head and neck cancer	1.3e-06	6.18e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.22e-06	5.84e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—AKT1—head and neck cancer	1e-06	4.77e-05	CbGpPWpGaD
